Robotic-assisted gait training (RAGT) may be the most effective form of physical exercise for improving mobility among people with severe…
Articles by Lindsey Shapiro, PhD
Pasithea Therapeutics investigational multiple sclerosis vaccine, PAS002, effectively delayed disease onset and reduced disease severity in a mouse…
After a relapse involving optic neuritis, or inflammation in the nerves connecting the eyes and brain, measurements of retinal thinning…
Tysabri (natalizumab) outperforms other disease-modifying therapies (DMTs) in its ability to lessen a range of patient-reported symptoms in…
Adding a specialized nurse practitioner (NP) to a neurologist-based standard care team was found to significantly lessen depression and anxiety…
Switching from a standard monthly course of Tysabri (natalizumab) to an extended-interval dosing administered every six weeks does not…
A set of receptors involved in dopamine signaling may play a key role in the activation of astrocytes, nerve support…
Breakthrough Health, a startup company that created the Emilyn mobile app to help people with multiple sclerosis (MS)…
Exercise prior to being diagnosed with multiple sclerosis (MS) was associated with less depression and anxiety among patients, likely…
Greater feelings of social support predicted better sleep quality in people with multiple sclerosis (MS) during the COVID-19…
Rune Labs has partnered with Coastal Research Institute (CRI) to identify new and noninvasive biomarkers of the loss…
An eight-week calorie-restricted diet plan — known as intermittent fasting — led to immune and metabolic changes among people with…
Helius Medical Technologies has launched an online training module for physical therapists who wish to use the company’s…
A six-week program combining yoga and group discussions about resilience led to significant reductions in fatigue and anxiety, and improvements…
Sepsis, a life-threatening response to an infection that can result in tissue damage and organ failure, was reported in nearly…
Delaying the start of disease-modifying therapies (DMTs) increases the risk of people with relapsing-remitting multiple sclerosis (RRMS) needing…
Smoking is associated with lower brain volume, more brain lesions, and greater disability and attention deficits among people with…
Lower levels of income and education, as well as other socioeconomic factors, are associated with the presence and severity of…
An assistive device made it significantly easier and more comfortable for multiple sclerosis (MS) patients with arm and hand…
The U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on Phase 3 trials testing the investigational…
Fatigue is a common symptom among people living with multiple sclerosis (MS), and has a significant negative impact on…
The Phase 3 RELEASE MSS1 clinical trial testing nabiximols oral spray failed to meet its primary goal of easing…
OM1 has created an artificial intelligence (AI)-based algorithm to estimate scores on the expanded disability status scale (EDSS),…
Ublituximab, an investigational antibody-based treatment for multiple sclerosis (MS), was efficacious across most patient subgroups, and led to marked…
A short course of high-dose methylprednisolone was associated with signs of mild liver injury in nearly 3% of multiple…
Autologous hematopoietic stem cell transplant (aHSCT) has shown some promise as a treatment option for highly active relapsing-remitting…
The risk of erectile dysfunction was about three times greater in men with multiple sclerosis (MS) compared with healthy…
The Multiple Sclerosis Society of Canada has opened MS Bike, an annual cycling event to raise awareness and funds for…
Alcohol intake is not significantly associated with an increased risk of developing multiple sclerosis (MS), but specifically drinking beer…
Cresence AS has sold its epidermal growth factor (EGF) platform comprising investigational therapies for multiple sclerosis (MS)…